Discover
BLRX
BioLineRx Ltd.
3.17
1 x 2.20
1 x 2.31
bid
ask
+
0.05
1.60%
1 @ 04:00 PM
3.17 +0.00 (0.00%)
| Ytd | 14.44% | |
| 1y | -30.02% |
3.09
day range
3.18
2.15
52 week range
5.06
| Open | 3.12 | Prev Close | 3.12 | Low | 3.09 | High | 3.18 | Mkt Cap | 14.26M |
| Vol | 15.15K | Avg Vol | 50.04K | EPS | N/A | P/E | N/A | Forward P/E | -1.06 |
| Beta | 0.87 | Short Ratio | 2.39 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.06 | 200-d Avg | 3.10 | 1yr Est | 4.57 |
| Income Statement | |||
| Total Revenue | 477.00K | ||
| Revenues (USD) | 477.00K | ||
| Cost of Revenue | 95.00K | ||
| Gross Profit | 382.00K | ||
| Operating Expenses | 3.39M | ||
| Research and Development Expense | 2.53M | ||
| Selling, General and Administrative Expense | 858.00K | ||
| Operating Income | -3.00M | ||
| Interest Expense | 250.00K | ||
| Net Income | -2.59M | ||
| Net Income Common Stock | -2.59M | ||
| Net Income Common Stock (USD) | -2.59M | ||
| Consolidated Income | -1.60M | ||
| Net Income to Non-Controlling Interests | 987.00K | ||
| Earning Before Interest & Taxes (EBIT) | -2.34M | ||
| Earning Before Interest & Taxes (USD) | -2.34M | ||
| Weighted Average Shares | 2.66B | ||
| Weighted Average Shares Diluted | 2.66B | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.35M | ||
| Cash and Equivalents (USD) | 17.35M | ||
| Trade and Non-Trade Receivables | 1.89M | ||
| Current Assets | 21.58M | ||
| Property, Plant & Equipment Net | 867.00K | ||
| Total Assets | 38.80M | ||
| Debt Current | 4.73M | ||
| Total Debt | 9.07M | ||
| Current Liabilities | 13.62M | ||
| Debt Non-Current | 4.34M | ||
| Total Liabilities | 17.96M | ||
| Accumulated Retained Earnings (Deficit) | -402.60M | ||
| Accumulated Other Comprehensive Income | -1.42M | ||
| Shareholders Equity | 16.67M | ||
| Shareholders Equity (USD) | 16.67M | ||
| Assets Non-Current | 17.22M | ||
| Total Debt (USD) | 9.07M | ||
| Goodwill and Intangible Assets | 16.35M | ||
| Inventory | 2.16M | ||
| Liabilities Non-Current | 4.34M | ||
| Trade and Non-Trade Payables | 4.91M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 88.00K | ||
| Net Cash Flow from Financing | -1.18M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -757.00K | ||
| Capital Expenditure | -6.00K | ||
| Issuance (Repayment) of Debt Securities | -1.18M | ||
| Net Cash Flow from Investing | 2.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.71M | ||
| Net Cash Flow from Operations | -2.28M | ||
| Effect of Exchange Rate Changes on Cash | 11.00K | ||
| Share Based Compensation | 78.00K | ||